Rvnc deadline: rvnc investors have opportunity to lead revance therapeutics, inc. securities fraud lawsuit

New york , march 1, 2025 /prnewswire/ -- rosen law firm, a global investor rights law firm, reminds purchasers of securities of revance therapeutics, inc. (nasdaq: rvnc) between february 29, 2024 and december 6, 2024, both dates inclusive (the "class period"), of the important march 4, 2025 lead plaintiff deadline. so what: if you purchased revance securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
RVNC Ratings Summary
RVNC Quant Ranking